News · June 29, 2026

Leadership Transition at CasInvent

Company news · Leadership

After four years of dedicated leadership, Dr. Alexander Scheer has stepped down as CEO of CasInvent. We sincerely thank Alexander for his commitment, vision, and the significant role he played in the company's growth. We wish him every success in his future endeavors.

Brno, Czech Republic

June 2026

CasInvent Pharma

We are pleased to welcome Dr. Kamil Paruch as our new CEO. Formerly Head of Chemistry, Kamil has been the driving force behind the development of our lead compounds and has made a lasting impact on CasInvent's scientific direction. As he takes on this new role, we wish him every success in leading CasInvent through its next chapter of innovation and growth.

CasInvent Pharma is a spin-off of Masaryk University developing best-in-class CK1 kinase inhibitors for treatment-resistant tumours. More information at casinvent.com.

All news